eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
7/2008
vol. 12
 
Share:
Share:
more
 
 
abstract:

Sorafenib in the treatment of metastatic renal cell cancer

Jakub Żołnierek

Współczesna Onkologia (2008) vol. 12; 7 (314–317)
Online publish date: 2008/11/03
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Renal cell carcinoma appears to be resistant to conventional treatment modalities. Introduction of advanced techniques of molecular biology into practice helped to establish the potent role of membrane receptors for growth factors, especially the component with activity of thyrosine kinases, in growth, proliferation, invasion and formation of metastatic lesions. One of the most investigated and advanced agents in clinical trials is sorafenib (Nexavar). The article is a short review of literature regarding the drug with special attention paid to clinical data.
keywords:

renal cell carcinoma, sorafenib tosylate, metastasis

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe